Lyme disease May 5, 2022 Adaptive Biotechnologies Making Inroads in MRD, Immune Medicine Businesses Premium Mar 29, 2022 Tufts University, NIH Leveraging Phospholipid Biomarkers to Develop Early Lyme Disease Test Premium Feb 16, 2022 Adaptive Biotechnologies to Focus on Immune Medicine, Minimal Residual Disease Testing Businesses Premium Nov 5, 2021 Adaptive Biotechnologies' T-Cell Assay Plans Boosted by Medicare Nod for COVID Test Premium Sep 10, 2021 IGeneX Launches New Immunoblot Test for Tick-borne Disease, Looks to Expand Infectious Disease Menu Premium May 6, 2021 Adaptive Biotech Touts Progress Toward Lyme and Gastrointestinal Disease Diagnostics Premium Apr 21, 2021 DiaSorin, Qiagen Obtain CE Mark for Lyme Disease Early Detection Test Apr 20, 2021 UK Researchers Publish Data on qPCR-Based Early-Stage Lyme Disease Test Premium Apr 2, 2021 Gold Standard Diagnostics Nabs FDA Clearance for Lyme Disease Test Mar 9, 2021 DiaSorin, Roche, Inova Diagnostics Receive FDA 510(k) Clearances in February Nov 11, 2020 Adaptive Biotechnologies Prepares to Launch T Cell-Based COVID-19 Test Jul 16, 2020 NIH Grants HelixBind $3M for Early Detection Lyme Test May 13, 2020 Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19 Feb 27, 2020 Adaptive Biotechnologies ImmunoSeq Dx Development Jolts Forward With Lyme Disease in Crosshairs Premium Dec 18, 2019 UCLA Team Develops Point-of-Care Assay for Early-Stage Lyme Disease Oct 21, 2019 Lyme Disease Test Could Enable 15-Minute Results at the Point of Care Premium Oct 18, 2019 IGeneX Gets New York State Approval for Tick-Borne Relapsing Fever Immunoblot Tests Oct 10, 2019 NIH Strategic Research Plan Aims to Improve Tickborne Disease Diagnosis, Detection Sep 20, 2019 Roche Gains FDA Clearance for Cobas Babesia Blood Test Aug 14, 2019 Adaptive Biotechnologies Plans New Product Launches, Expanded FDA Label for ClonoSeq Premium Load More Breaking News KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure 360Dx Top 30 Grows 8 Percent, Continues Upward Climb HemoSonics Nabs FDA 510(k) for Cartridge-Based Blood Hemostasis Assay Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay
